The complete hospital and community records of 77 women were randomly selected from 232 women who had relapsed breast cancer between 2000 and 2005. Scrutiny of all management activities revealed a total cost of £1 939 329 (mean per patient of £25 186, 95% CI £13 705-£33 821). The median survival from time of relapse was 40.07 months and the median total cost per patient was £31 402.62. Including the community cost of a relapse provides a more realistic figure for future cost-effectiveness analysis of adjuvant breast cancer therapies. © 2009 Cancer Research UK.
CITATION STYLE
Thomas, R. J., Williams, M., Marshall, C., Glen, J., & Callam, M. (2009). The total hospital and community UK costs of managing patients with relapsed breast cancer. British Journal of Cancer, 100(4), 598–600. https://doi.org/10.1038/sj.bjc.6604911
Mendeley helps you to discover research relevant for your work.